01-December-2022

Addictions Therapeutics Market Analysis 2023-2027: North America will Dominate the Market Growth 

The addiction therapeutics market share is forecast to reach USD 9.86 billion, after growing at a CAGR of 7.65% during 2023-2027. The high consumption of alcohol, tobacco, and opioid products is analyzed to boost the addictions therapeutics market growth. Moreover, increasing R&D of novel drugs is the major trend enhancing the overall market demand for addiction therapeutics during the forecast period.   

Get a Snapshot on the Addiction Therapeutics Market Analysis: Unlock the Free Sample Report 

Addictions Therapeutics Market Analysis 2023-2027: North America will Dominate the Market Growth Technavio’s report on: “Addictions Therapeutics Market by Type, Distribution Channel, and Geography - Forecast and Analysis 2023-2027" covers an in-depth analysis of the following segments of the addiction therapeutics market. 

Distribution channel 

  • Hospital pharmacy: The addiction therapeutics market growth by the hospital pharmacy segment will be significant during the forecast period.  Hospital pharmacies experience increasing demand for addiction therapeutics due to factors such as good discounts, improving reimbursement, and the growing number of drug addicts. 

  • Retail pharmacy 

Geography 

  • North America: The increasing consumption of alcohol, tobacco, and opioids in the US and Canada will contribute 45% of market growth by 2027. 

  • Europe 

  • Asia 

  • Rest of World (ROW) 

Type 

  • Alcohol addiction therapeutics 

  • Tobacco addiction therapeutics 

  • Drug addiction therapeutics 

Key Takeaways: 

  • The addiction therapeutics market size will witness a YOY Growth Rate of 6.56% in 2023.  

  • The presence of generics will be a major challenge for the addiction therapeutics market during the forecast period. 

  • Major addiction therapeutics market vendors include: Amneal Pharmaceuticals Inc., Aphios Corp., Braeburn Inc., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Hikma, Pharmaceuticals Plc, Indivior Plc, Johnson and Johnson, Kaleo Inc., Mallinckrodt Plc, Orexo AB, Otsuka Holdings Co. Ltd., Pfizer Inc., Purdue Pharma LP, Sun Pharmaceutical, Industries Ltd., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Viatris Inc. 

  • The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the US, Canada, Germany, the UK, and France. 

Download the Free PDF Sample Report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth. 

Key Data Covered in the Addiction Therapeutics Market Report 

  • Precise market size estimation during the forecast period 2023-2027.  

  • CAGR of the addiction therapeutics market forecast during 2023-2027.  

  • Market-level data on units, average selling prices, and values of the addiction therapeutics market share.  

  • Prediction of the upcoming trends, drivers, and factors that challenge the growth of the addiction therapeutics market.  

  • Addiction therapeutics industry growth across North America, Europe, Asia, and Rest of World (ROW).

Read More Read Less
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>